Diazenes as modificators of drug-resistance in tumor cells

Neoplasma

Volumn 47, Issue 6, 2000, Pages 390-395

  Osmak, M ^a   Bordukalo, T ^a   Ambriovic Ristov, A ^a   Jernej, B ^a   Kosmrlj, J ^a   Polanc, S ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Diazenes; Drug resistance; Glutathione; Tumor cells

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; GLUTATHIONE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CYTOTOXICITY; HUMAN; HUMAN CELL; LARYNX CARCINOMA; TUMOR CELL; UTERINE CERVIX CARCINOMA;

EID: 0033635333     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Resistance to cisplatin
2. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): Cross-resistance pattern
3. Molecular basis of cis-diamminedichloroplatinum(II) resistance: A review
4. Augmentation of cisplatin (DDP) cytotoxicity in vivo by D,L-buthionine sulfoximine (BSO) in DDP-sensitive and -resistant rat ovarian tumors and its relation to DNA interstrand cross links
5. An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells
6. Mechanisms of resistance of human tumours to anticancer drugs of the platinum family: A review
7. Clinical relevance of drug resistance genes in malignant diseases
8. Apoptosis: Molecular mechanisms and implications for cancer chemotherapy
9. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
10. An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivity to antitumor agents shown by a range of human tumour cell lines
11. A mild approach to 1,3,4-oxidiazoles and fused 1,2,4-traizoles. Diazenes as intermediates?
12. Controlled oxidation of thiols to disulfides by diazenecarboxamides
13. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines
14. Biology of the multidrug resistance-associated protein, MRP
15. Biophysical characterization of zinc ejection from HIV nucleo-capsid protein by anti-HIV 2,2'-dithiobis(benzamides) and benzisothiazolones
16. Glutathione, ascorbate, and cellular protection
17. Cellular resistance to anthracyclines
18. Molecular alterations induced in drug-resistant cells
19. Resistance of human larynx carcinoma cells to cisplatin, gamma irradiation and methotrexate do not involve overexpression of c-myc or c-Ki-ras oncogenes
20. Characterization of carboplatin-resistant sublines derived from human larynx carcinoma cells
21. Diazene JK-279: Potential anticancer drug
22. Diazense: Modificators of tumor cell resistance to cisplatin
23. The characterization of two human cervical carcinoma HeLa sublines resistant to cisplatin
24. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidans: Oxidative stress as a modulator of apoptosis
25. Apoptosis and therapy
26. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues
27. Regulation by glutathione of drug transport in multidrug resistant human lung tumour cell lines overexpressing MRP
28. Reversing drug resistance in bcl2-expressing tumor cells by depleting glutathione
29. Glutathione deficiency in human disease
30. Glutathione-related mechanisms in cellular resistance to anticancer drugs. Review
31. Role of glutathione in the export of compounds from cells by multidrug-resistance-associated protein